AU1740692A - New medicinal use - Google Patents

New medicinal use

Info

Publication number
AU1740692A
AU1740692A AU17406/92A AU1740692A AU1740692A AU 1740692 A AU1740692 A AU 1740692A AU 17406/92 A AU17406/92 A AU 17406/92A AU 1740692 A AU1740692 A AU 1740692A AU 1740692 A AU1740692 A AU 1740692A
Authority
AU
Australia
Prior art keywords
medicinal use
new medicinal
new
medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17406/92A
Inventor
Martin Kanje
Mats Lake
Anna Skottner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Kabi Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia AB filed Critical Kabi Pharmacia AB
Publication of AU1740692A publication Critical patent/AU1740692A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
AU17406/92A 1991-05-03 1992-04-27 New medicinal use Abandoned AU1740692A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9101341A SE9101341D0 (en) 1991-05-03 1991-05-03 NEW MEDICINAL USE
SE9101341 1991-05-03

Publications (1)

Publication Number Publication Date
AU1740692A true AU1740692A (en) 1992-12-21

Family

ID=20382638

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17406/92A Abandoned AU1740692A (en) 1991-05-03 1992-04-27 New medicinal use

Country Status (3)

Country Link
AU (1) AU1740692A (en)
SE (1) SE9101341D0 (en)
WO (1) WO1992019256A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9310049D0 (en) * 1993-05-12 1993-06-30 Cancer Res Campaign Tech Growth factor effects
CA2176708A1 (en) * 1993-11-15 1995-05-26 Christopher A. Maack Method of treating neurological disorders
GB0011278D0 (en) 2000-05-10 2000-06-28 Univ London Repair of nerve damage
GB0202906D0 (en) 2002-02-07 2002-03-27 Univ London Prevention of myocardial damage

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5093317A (en) * 1989-06-05 1992-03-03 Cephalon, Inc. Treating disorders by application of insulin-like growth factor
JPH0525056A (en) * 1989-07-27 1993-02-02 Max Planck Inst Fuer Saikaiatorii Adjustment of nerve growth factor synthesis in central nervous system

Also Published As

Publication number Publication date
WO1992019256A1 (en) 1992-11-12
SE9101341D0 (en) 1991-05-03

Similar Documents

Publication Publication Date Title
AU1219292A (en) Inhaler
AU2421192A (en) Inhaler
AU6018194A (en) Easy intubator
AU2263692A (en) Multiple pharmaceutical syringe
AU3888793A (en) Novel medicament
AU2087992A (en) Pharmaceutical combination formulation
AU2470792A (en) Wheelchair
GB9121204D0 (en) Medicament
AU9128891A (en) Single use syringe
AU2954692A (en) Medical preparations
AU2838192A (en) Catheter
GB9121463D0 (en) Medicament
AU1189392A (en) Pharmaceutical agent
AU649061B2 (en) Single use syringe
AU662160B2 (en) Analgesic
GB9317752D0 (en) New pharmaceutical use
AU2493792A (en) Pharmaceutical preparation
AU1740692A (en) New medicinal use
AU1209092A (en) Articulator
AU3885995A (en) Novel medicinal use
AU1015192A (en) (s)-11-hydroxy-10-methylaporphine
GB9123202D0 (en) New pharmaceutical use
GB9104307D0 (en) New pharmaceutical use
GB9113850D0 (en) New pharmaceutical use
GB9113918D0 (en) New pharmaceutical use